NAXION
Kerry Monaghan is a Senior Research Analyst at NAXION, having joined the company in June 2022, previously holding the position of Research Analyst. Prior to this role, Kerry served as Treasurer for Kappa Kappa Gamma from January 2021 to May 2022, where responsibilities included creating and managing a budget of $115,000, regulating financial transactions, and liaising with the sorority’s financial headquarters. Kerry holds a Bachelor of Arts in Economics and Political Science from Villanova University, graduating in 2022, and previously earned a high school diploma from Bishop Eustace Prep School in 2018.
This person is not in the org chart
NAXION
Our Enterprise Mission NAXION is a broadly-resourced, nimble boutique that relies on advanced analytics, data integration, and sector experience to help businesses direct the destinies of their brands. The firm is distinguished by a genuine synthesis of research proficiency and astute business consulting, supported by one of the industry’s most inventive and customizable toolkits. The acuity of our thinking is matched by the exceptional quality of our process. Our Origins & Culture NAXION’s hybrid “enterprise DNA” is rooted in century-old origins as the world’s first business intelligence firm, National Analysts, which played a critical role in the development of the discipline. Subsequent decades as a division of Booz.Allen & Hamilton established a new leadership role for the firm in advancing data-driven decision cultures across a range of industries. Today, NAXION is an independent, employee and woman-owned firm fiercely dedicated to industry leadership and innovation. Our exceptional commitment to client service and partnership is enabled by a unique boutique culture offering global decision support. Our Services & Sectors NAXION engagements routinely address market entry strategy and customer segmentation, opportunity assessment and forecasting, product development, brand value creation and strength, customer experience, pricing strategy, and lifecycle management. Our specialized NAscence Group supports Life Sciences innovation and commercialization with a suite of services scaled to Big Pharma or emerging Biotech, including forecasting, clinical trials design, and market entry strategy. Specialized industry practices include Health & Life Sciences, Financial Services, Information Technology, Consumer Products, Building & Industrial Systems, Vehicles & Heavy Equipment, and Energy. Depth of experience across a range of B2B industries equips us to help client enterprises understand and meet the needs of business customers in complex market ecosystems.